Studies on agents with mixed NO-dependent vasodilating and β-blocking activities

Pharmaceutical Research

Volumn 14, Issue 12, 1997, Pages 1750-1758

  Boschi, Donatella ^a   Di Stilo, Antonella ^a   Cena, Clara ^a   Lolli, Marco ^a   Fruttero, Roberta ^a   Gasco, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

blockers; Furoxans; Hybrid drugs; NO donors; Vasodilation

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; FURAZAN DERIVATIVE; NITRIC OXIDE DONOR;

ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; HEART RIGHT ATRIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRACHEA; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DRUG DESIGN; GUINEA PIGS; HEART; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OXADIAZOLES; PROPRANOLOL; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; TRACHEA; VASODILATOR AGENTS;

EID: 0031414668     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012136030849     Document Type: Article

References (25)

1. B. J. R. Nicolaus. Symbiotic Approach to Drug Design. In Decision Making in Drug Research; Gross, F. Ed.; Raven Press: New York, 1983; pp 173-186.
2. a) P. A. Van Zwieten. J. Hypertens. 8:687-696 (1990);
3. b) P. A. Van Zwieten. Drugs. 45:509-517 (1993).
4. J. A. M. Christiaans and H. Timmerman. Eur. J. Phar. Sci. 4:1-22 (1996).
5. J. F. Kerwin, Jr., J. R. Lancaster, Jr., and P. L. Feldman. J. Med. Chem. 38:4343-4362 (1995).
6. A. Gasco, R. Fruttero, and G. Sorba. Il Farmaco 51:617-635 (1996).
7. D. Ghigo, R. Heller, R. Calvino, P. Alessio, R. Fruttero, A. Gasco, A. Bosia, and G. Pescarmona. Biochem. Pharmacol. 43:1281-1288 (1992).
8. M. Feelish, K. Schönafinger, and E. Noack. Biochem. Pharmacol. 44:1149-1157 (1992).
9. R. Ferioli, G. C. Folco, C. Ferretti, A. M. Gasco, C. Medana, R. Fruttero, M. Civelli, and A. Gasco. Br. J. Pharmacol. 114:816-820 (1995).
10. A. Di Stilo, C. Cena, A. M. Gasco, A. Gasco, D. Ghigo, and A. Bosia. Bioorg. Med. Chem. Lett. 6:2607-2612 (1997).
11. M. Hecker, W. Vorhoff, A. T. Bara, P. I. Mordvintcev, and R. Busse. Nauny-Schmiedeberg's Arch. Pharmacol. 351:426-432 (1995).
12. C. Medana, G. Ermondi, R. Fruttero, A. Di Stilo, C. Ferretti, and A. Gasco. J. Med. Chem. 37:4412-4416 (1994).
13. G. Sorba, C. Medana, R. Fruttero, C. Cena, A. Di Stilo, U. Galli, and A. Gasco. J. Med. Chem. 40:463-469 (1997).
14. H. Bohn, J. Brendel, P. A. Martorana, and K. Schönafinger. Br. J. Pharmacol. 114:1605-1612 (1995).
15. R. Fruttero, D. Boschi, A. Di Stilo and A. Gasco. J. Med. Chem. 38:4944-4949 (1995).
16. B. G. Main, β-Adrenergic Receptors. In Comprehensive Medicinal Chemistry. Hansch, C. Ed; Pergamon Press, Oxford, 1990. Vol 3, pp 188-228.
17. G. Sorba, G. Ermondi, R. Fruttero, U. Galli and A. Gasco. J. Heterocycl. Chem. 33:327-334 (1996).
18. R. Calvino, V. Mortarini, A. Gasco, A. Sanfilippo, and M. L. Ricciardi. Eur. J. Med. Chem. 15:485-487 (1980).
19. C. Grundman, G. W. Nickel, and R. K. Bansal. Liebigs Ann. Chem. 1029-1050 (1975).
20. E. R. Marie. J. Chem. Soc. 101:305-317 (1912).
21. A. M. Gasco, R. Fruttero, G. Sorba, and A. Gasco. Liebigs Ann. Chem. 1211-1213 (1991).
22. D. Atlas, M. L. Steer, and A. Levitzki. Proc. Natl. Acad. Sci. USA 73:1921-1925 (1976).
23. A. P. Krapto and C. S. Kuell. Synth. Comm. 20:2559-2564 (1990).
24. L. E. Overman and L. A. Flippin. Tetrahedron Lett. 22:195-198 (1981).
25. J. R. Lancaster, Jr. Proc. Natl. Acad. Sci. USA. 91:8137-8141 (1994).